Hans Fritz
Ludwig Maximilian University of Munich
326 Papers
4.7K Citations
Hans Fritz is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Acrosin & Trypsin. The author has an hindex of 52, co-authored 326 publications. Previous affiliations of Hans Fritz include Austral University of Chile & University of Mainz.
Chat about Author
Papers
Chemistry and biochemistry of proteinase inhibitors from mammalian tissues
TL;DR: The trypsin method for producing insoluble resins with kallikrein and chymotrypsin was succeeded in using, and it was demonstrated that the Kunitz-inhibitor is still capable of inhibiting esterolytic activity of thetrypsin resin.
The Primary Structure of Porcine Glandular Kallikreins
Harald Tschesche,Gerhard Mair,Gudrun Godec,Franz Fiedler,Werner Ehret,Christa Hirschauer,Marius Lemon,Hans Fritz,Gunther Schmidt-Kastner,Carl Dr Kutzbach +9 more
TL;DR: Comparison of the amino acid sequence of the A- and B-chains of porcine pancreatic kallikrein B and identity of the N-terminal sequences of pancreatic, submandibular and urinary kall Kikrein reveal the same genetic origin of the three glandular kallkreins.
Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma
Christian Waydhas,Dieter Nast-Kolb,Marianne Jochum,Arnold Trupka,Susann Lenk,Hans Fritz,Karl-Heimo Duswald,Leonhard Schweiberer +7 more
TL;DR: The data indicate that infection might not play a crucial role in the pathogenesis of posttraumatic OF in a substantial portion of patients with trauma, and only polymorphonuclear leukocyte-elastase showed a difference between patients with and without infection or sepsis.
Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA.
TL;DR: The final purification of two thrombin-inhibiting preparations by reversed-phase high-performance liquid chromatography yielded several isohirudins with either N-terminal valine or isoleucine but with identical inhibition characteristics, i.e. specific throm bin inhibiting activities of 680-720 IU/mg.